Leukaemia inhibitory factor (LIF) plays an essential role during cell differentiation and implantation in the mouse exerting its effects via the two dimerizing receptor subunits glycoprotein 130 (gp130) and LIF-receptor β (LR-β). This study investigated the mRNA expression of bovine LIF (bLIF), gp130 and LR-β in pooled or individual bovine oocytes and embryos generated in vitro or in vivo after superovulation. Transcripts of gp130 and LR-β were detectable in as little material as 1/3 oocyte equivalent and bLIF transcripts in two embryo equivalents employing a simple, rapid and robust one-step reverse transcription-polymerase chain reaction (RT-PCR) protocol using random hexamer priming during reverse transcription and 60 amplification cycles in the PCR. All mRNA fragments were also found in cumulus cells and various bovine tissues. While gp130 and LR-β mRNA were present in pooled material throughout embryo development in vitro from the immature oocyte to the hatched blastocyst, bLIF-transcripts were absent in immature oocytes, inconsistently expressed from the matured oocyte up to the 16-cell stage as well as in blastocysts dependent on embryo batch. It was not found in morulae, but again present in hatched blastocysts. In contrast, in in-vivo derived embryos no bLIF was found, LR-β was not detected at the morula to blastocyst transition while gp130 transcripts were observed from the morula to the hatched blastocyst. In individual embryos the mRNA expression pattern was similar for both in-vitro and in-vivo derived embryos as found in pooled material. These results indicate perturbation of the mRNA expression pattern of the specific LIF-LIF-receptor system in embryos generated in vitro that could lead to abnormal differentiation of the cell compartments forming the blastocyst. Cumulus cells, frequently used as supportive factor in co-culture in bovine in-vitro embryo production, are a rich source of the LIF-LIF-receptor system acting in a paracrine and/or autocrine manner. The biological function of the LIF-LIF-receptor system during bovine preimplantation development warrants further investigation.
Introduction
Leukaemia inhibitory factor (LIF) plays an essential role during early embryonic development (Smith et al., 1992; Stewart, 1994) . LIF exerts its biological effects via binding to a specific receptor system: leukaemia inhibitory factor receptor β (LR-β) and glycoprotein 130 (gp130). While LR-β serves as the specific binding subunit for the LIF-ligand, the gp130 subunit is similarly used by other cytokines (Hilton, 1992) . By dimerization of these two subunits within the cell membrane an intracellular signal cascade is activated to regulate transcription and DNA synthesis within the nucleus via various transcription factors (Gearing, 1993; Stahl et al., 1994; Ihle and Kerr, 1995) depending on cell type and differentiation status (Hilton, 1992; Metcalf, 1992; Kishimoto et al., 1994) . Despite a high degree of homology at the protein, as well as at the mRNA, level of the LIF-LIF-receptor system between different species (Willson et al., 1992) , varying functions of the homologous or heterologous LIF proteins have been suggested (Fry, 1992) . Soluble forms of LR-β or gp130 have been isolated from human serum (Layton et al., 1992; Narazaki et al., 1993; Rose-John and Heinrich, 1994) . Two isoforms of murine LIF have been identified: diffusible LIF and matrix-associated LIF (Rathjen et al., 1990) .
Maternal LIF was found as mRNA or protein in the uterus of several species around implantation (Bhatt et al., 1991; Anegon et al., 1994; Charnock-Jones et al., 1994; Yang et al., 1994 Yang et al., , 1995 and similarly in bovine endometrial tissue (Brisson et al., 1996; Oshima et al., 1998) . While gp130 was strongly expressed in non-pregnant human endometrium, LR-β was found only during pregnancy (Kojima et al., 1995) .
While murine knockout models for gp130 died between days 12.5 and term (Yoshida et al., 1996) , LR-β-knockouts were delivered but with disorders (Ware et al., 1995) , while in LIF-knockouts the blastocysts were not able to implant (Stewart et al., 1992; Escary et al., 1993) .
LIF mRNA has been detected in murine morulae and blastocysts (Conquet and Brulet, 1990; Murray et al., 1990; Nichols et al., 1996) but not in human blastocysts (CharnockJones et al., 1994; Sharkey et al., 1995) . LIF is involved in the temporal regulation of proteinase activity in the murine blastocyst which is required for uterine invasion during establishment of pregnancy (Harvey et al., 1995) . Overexpression of the diffusible mLIF in murine blastocysts did not change phenotype while overexpression of the matrixassociated form was correlated with abnormal gastrulation (Conquet et al., 1992) . mRNA for both receptor subunits was found for the first time during development in the murine blastocyst stage in vivo (Murray et al., 1990; Harvey et al., 1995; Nichols et al., 1996) as well as in in-vitro or in-vivoderived human embryos from the oocyte up to the hatched blastocyst (Charnock-Jones et al., 1994; Sharkey et al., 1995; VanEijk et al., 1996) . The mRNA expression pattern of the LIF-LIF-receptor system has not been studied in preimplantation embryos from domestic species.
Several cell lines known to support embryonic development in vitro produce LIF (Smith et al., 1987; Kauma and Matt, 1995; Desai and Goldfarb, 1996; Reinhart et al., 1998) . Addition of exogenous LIF to in-vitro culture media enhanced development of human (Dunglison et al., 1996) , murine (Mitchel et al., 1994) , ovine and bovine (Fukui and Matsuyama, 1994; Han et al., 1995; Margawati et al., 1995a,b) preimplantation embryos. Extended in-vitro culture of bovine preimplantation embryos has been shown to perturbate the well orchestrated gene expression pattern necessary for a normal development (Wrenzycki et al., 1996 (Wrenzycki et al., , 1998a . These perturbations are suggested to affect not only preimplantation development and fetal outgrowth but also perinatal and adult life (Walker et al., 1996; Kruip and DenDaas, 1997; Eppig and O'Brian, 1998) .
Here we report the mRNA expression pattern of the LIF-LIF-receptor system throughout bovine preimplantation development in vitro and in vivo employing a sensitive reverse transcription-polymerase chain reaction (RT-PCR) assay. By using pools of embryos a representative mRNA expression pattern should be determined before single embryos were analysed to elucidate differences between individual embryos.
Materials and methods
Embryo production in vitro and in vivo Bovine cumulus-oocyte complexes (COC) were isolated from slaughterhouse ovaries by slicing with razor blades and flushed into phosphate-buffered saline (PBS; Sigma Chemical Co, St Louis, MO, USA) with 0.1% bovine serum albumin (BSA, fraction V; Sigma) and 2 IU heparin (Serva, Heidelberg, Germany). Only intact COC with at least three layers of cumulus cells surrounding an oocyte with homogenous cytoplasm were collected into TCM-air (TCM199 containing L-glutamine and 25 mM HEPES (Sigma) supplemented with 22 µg/ml pyruvate, 350 µg/ml NaHCO 3 , 50 µg/ml gentamicin and 0.1% BSA). Subsequently they were matured for 24 h in 100 µl drops of TCM199 with 2.2 µg/ml NaHCO 3 in the presence of 0.1% BSA, 1 µg/ml oestradiol 17-β (Serva), 0.5 µg/ml FSH (follicle stimulating hormone, Folltropin; Vetrepharm, London, Ontario, Canada) and 0.06 IU/ml human chorionic gonadotrophin (HCG, Ekluton; Vemie, Kempen, Germany). 1ϫ10 6 /ml swim-up separated spermatozoa from one bull with proven fertility in vitro was used for fertilization in Fert-Talp containing 0.6% BSA and 10 µM hypotaurine (Sigma), 1 µM epinephrine (Sigma) and 0.1 IU heparin (Serva). After 19 h of sperm-oocyte coincubation presumptive zygotes were washed off adhering spermatozoa under microscopic examination (magnification ϫ200) and cultured in 200 µl drops of TCM199 supplemented with 0.1% BSA. All incubations were performed at 39°C in 5% CO 2 in humidified air in groups of 15-20 oocytes/embryos per droplet under silicone oil (Serva) (Eckert and Niemann, 1995) .
Oocytes/embryos were cultured until the desired stage (maximum 8 days) and then denuded mechanically, washed at least three times 958 in PBS supplemented with 0.1% polyvinyl alcohol (PVA; Sigma) and after final control for the absence of contaminating cumulus cells or adhering spermatozoa at ϫ200 magnification frozen either as single oocytes/embryos or in groups (up to 40 oocytes) in 0.5 ml cups at -80°C until further use. Morphologically intact immature oocytes were collected after slicing, matured oocytes after 24 h of in-vitro maturation (visible polar body, ϫ200 magnification), zygotes after 19 h of oocyte-sperm coincubation (two pronuclei and two visible polar bodies, ϫ400 magnification), 2-4 cell stages on day 2.5-3 of in-vitro culture, 8-16 cell stages on day 3.5-4, compact morulae on day 5.5-6, blastocysts on day 7.5-8 and hatched blastocysts on day 8. Only embryos of good quality with no (early cleavage stages) or Ͻ10% of the total cells (from compact morula onwards) visible cell detritus were selected for the experiments. Furthermore, only oocytes/embryos derived from in-vitro production runs with at least 65% maturation and normal fertilization, 60% cleavage, 35% development to morulae and 20% to blastocysts were used for RT-PCR. Embryos that had not reached the desired developmental stage at the above time points were discarded.
Cumulus cells were collected at the day of slicing, after 24 h of maturation in vitro or after a 10 and 20 day culture, washed carefully in PBS with 0.1% PVA and stored frozen at -80°C until further use.
For in-vivo production of morulae, blastocysts and hatched blastocysts, ovulation was stimulated in Holstein Friesian donor cows with a single i.m. injection of 3000 IU pregnant mare's serum gonadotrophin (PMSG, Brumegon; Hydrochemie, Munich, Germany) between days 9 and 13 of the oestrous cycle followed by injection of prostaglandin 2 α (Clopostrenol, Estrumate; Pitman-Moore, Burgwedel, Germany) 48 h later. When oestrous was detected 48 h later, donors were inseminated twice at an interval of 12 h with semen from the same bull and batch as used for in-vitro fertilization. Embryos were recovered by flushing of the uterine horns on day 7 or 8 with 300 ml PBS containing 1% newborn calf serum (NBCS). Only grade I and II embryos (Wrenzycki et al., 1996) were collected, washed and frozen as described above.
Differential staining of inner cell mass (ICM) and trophectoderm cells of blastocysts produced in vitro
For determination of total cell numbers and the ratio of ICM to trophectodermal cells in in-vitro produced bovine embryos the differential staining procedure was performed with a representative sample of day 8 blastocysts according to the protocol described for bovine blastocysts (Kreysing et al., 1997) . Briefly, after removal of the zona pellucida with 1.5% pronase (Typ XXV; Sigma) in PBS (w/v), the trophectoderm cells were marked by an anti-bovine-spleen rabbit antiserum (30 min at 39°C), subsequently lysed with guinea pig complement (Sigma) and stained with propidium iodide (Sigma) (30 min at 39°C). Finally, the embryos were kept in ethanol with Hoechst 33258 overnight. Under a phase-contrast microscope (excitation filter at 420 nm, barrier filter at 365 nm) trophectoderm cells were identified by the pink fluorescence of propidium iodide and ICM cells were recognized by their blue fluorescence due to bisbenzimide. Embryos in which clear cell evaluation failed or that were disrupted during the staining procedure were discarded.
Isolation of RNA
For isolation of tissue RNA a total RNA isolation reagent (TRIzol Reagent; Gibco BRL, Eggenstein, Germany) was used according to the manufacturer's instructions. Final concentration of the total RNA was adjusted to 1 µg/µl water after concentration had been determined spectrophotometrically (GeneQuant; Pharmacia, Freiburg, Germany). Only RNA with a purity higher than 1.65 (OD 260nm / OD 280nm ) was used for RT-PCR after digestion with 1 IU DNase I (Boehringer, Mannheim, Germany) per 2 µg total RNA (30 min at 37°C, 80°C for 10 min, chilling on ice). Total RNA was then stored frozen (-80°C) in aliquots until further use for RT-PCR.
A Dynabeads mRNA DIRECT Kit (Dynal, Oslo, Norway) was employed for isolation of Poly(A) ϩ RNA according to the manufacturer's instructions with minor modifications (Wrenzycki et al., 1998a,b) . Briefly, lysis of cumulus cells and pooled or single oocytes/ embryos was accomplished by adding 150 µl of lysis/binding buffer (100 mM Tris-HCl, pH 8.0, 500 mM LiCl, 10mM EDTA, 1% LiDS, 5 mM dithiothreitol), vortexing, centrifugation and incubation at room temperature for 10 min. Afterwards, 10 µl of prewashed Dynabeads Oligo (dt) 25 were added and incubated for 5 min at room temperature to obtain binding of Poly(A) ϩ RNA to the beads. Separation of the beads was performed with a Dynal MPC-E-1 magnetic separator with two washing steps in washing buffer 1 (10 mM Tris-HCl, pH 8.0, 0.15 M LiCl, 1 mM EDTA, 0.1% LiDs) and three steps in washing buffer 2 (10 mM Tris-HCl, pH 8.0, 0.15 M LiCl, 1 mM EDTA). Finally, Poly(A) ϩ RNA was eluted from the beads in 11 µl sterile water by a 2 min incubation at 65°C and used immediately for reverse transcription (RT) after further dilution for the appropriate oocyte/ embryo equivalent content to fit the RT volume (1/3 embryo equivalent/5.5 µl water -40 oocyte equivalents/5.5 µl water). The concentration of Poly(A) ϩ RNA derived from cumulus cells collected from 15 immature oocytes was determined via spectrophotometry.
Reverse transcription
Total tissue RNA (various dilutions ranging from 1 µg to 1 pg) as well as Poly(A) ϩ RNA isolated from different groups of oocytes or embryos (single embryos or up to 40 oocytes, for details see below and Figure 1 ) and cumulus cells (Ͻ14 ng Poly(A) ϩ RNA per specific transcript) was reverse transcribed into cDNA in a total volume of 10 µl consisting of 1ϫ RT buffer (50 mM KCl, 10mM Tris-HCl, pH 8.3; Perkin-Elmer, Vaterstetten, Germany), 5 mM MgCl 2 , 1 mM of each dNTP (Amersham, Brunswick, Germany), 2.5 µM random hexamers (Perkin-Elmer), 10 IU RNase inhibitor (Perkin-Elmer) and 25 IU Moloney Murine Leukaemia Virus reverse transcriptase (PerkinElmer). Specific priming did not enhance specificity and sensitivity of the assay. To prevent evaporation, the RT reaction was carried out under mineral oil in a PTC-200 thermocycler (MJ Research, Watertown, MA, USA) with a preincubation step of 10 min at 25°C followed by 1 h at 42°C and by a 5 min. denaturation step at 99°C before cooling to 4°C.
Polymerase chain reaction
The PCR reaction was performed in the same tube as the RT reaction without removal from the thermocycler (one step RT-PCR) in a total volume of 100 µl of 1ϫ PCR buffer (20 mM Tris-HCl, pH 8.4, 50 mM KCl; Gibco BRL), 1.5 mM MgCl, 200 µM of each dNTP and 1 µM of each sequence specific primer. During hot start, 2 IU Taq DNA polymerase (Gibco) were added at 72°C. PCR primers (see Table I ) were designed from the coding regions of each gene sequence using the OLIGO-program (Oligo 4.1 Primer Analysis Software, National Biosciences Inc., Plymouth, USA).
The PCR amplification protocol employed for this study with the highest reproducibility, sensitivity and specificity consisted of an initial step at 99°C for 5 min followed by 72°C for 2 min. (hot start), 60 cycles of 15 s each at 95°C for denaturation, optimal annealing temperature corresponding to each specific primer pair (see Table I ), and at 72°C for extension. After the last cycle a final 5 min extension period at 72°C was followed by cooling to 4°C. The Poly(A)polymerase fragment used as positive control was sufficiently amplified after 35 cycles. A further increase of the cycle number or the concentration of Taq polymerase could not enhance the sensitivity of our RT-PCR assay.
For visualizing the amplified fragments 10 µl of 10ϫ loading buffer (0.25% xylenecyanol and 25 mM EDTA in 50% glycerin) were added to the RT-PCR products prior to electrophoresis on a 2% agarose gel containing 0.5 µg/ml ethidium bromide. Each gel was photographed on a 312 nm UV-transilluminator and fragment lengths were estimated using a molecular weight marker (100 bp DNA Ladder; Gibco).
As negative controls, tubes lacking either sample RNA (contamination with exogenous RNA or DNA) or reverse transcriptase (contamination with genomic DNA) were prepared in parallel for each specific primer pair during each RT-PCR run. In addition, culture medium, but without oocytes/embryos, derived from each invitro production run was treated in parallel to the collected embryos. Poly(A) ϩ RNA derived from cumulus cells served as positive control in the RT-PCR assay for detection of the LIF-LIF-receptor system when embryos were investigated. As indicator for the presence of intact RNA derived either from embryos or various tissues, the detection of Poly(A) mRNA was used as a positive control.
The identity of each RT-PCR fragment was confirmed by sequencing using an automated sequencing device (DNA sequencer, model 4000L; Li-Cor, Lincoln, Nebraska, USA). The sequences obtained were aligned with published sequences via the Basic Local Alignment Search Tool, Internet (BLAST) program to exclude possible mismatches of the primers used in our study with other known sequences.
Detection of LIF-LIF-receptor system RNA in bovine tissue and validation of the RT-PCR assay
Various bovine tissue RNA was screened for the presence or absence of transcripts for the LIF-LIF-receptor system. Uterus, oviduct, spleen, corpus luteum and liver from an oestrous cow as well as uterus, oviduct, corpus luteum and placenta from two first trimester pregnant cows and liver from a third trimester pregnant animal were used for RNA extraction and subsequent RT-PCR. Spleen, liver and intestine from the corresponding fetuses (two from the first trimester and one from the third trimester of pregnancy) were analysed in parallel. Different RNA concentrations were used to determine sensitivity and specificity of the one-step RT-PCR assay. For LR-β, consistent fragment amplification from bovine material with primers based on the published human or murine sequences was obtained only if 1 µg total RNA was employed. However, this was not sufficiently sensitive when bovine embryonic RNA was employed. One primer pair based on the human sequence was used for the generation of an LR-β-fragment (Tomida et al., 1993) from the various bovine tissues. These fragments were either cut out from the gel or the PCR product was used directly for sequencing after purification (QUIAquick gel extraction Kit or QUIAquick PCR Purification Kit respectively, Qiagen, Hilden, Germany). Fragments derived from adult or fetal liver as well as fetal spleen were sequenced using an automated sequencing and a sequencing kit (Amersham Sequenase fluorescent labelled sequencing kit) according to the manufacturer's instructions. Alignment of these sequences and comparison with the known murine and human sequences revealed minor modifications in the bovine fragment. Based on this bovine specific sequence a new bovine specific primer pair was designed (Table I) .
Detection of LIF-LIF-receptor system mRNA in pooled bovine embryos In this experiment Poly(A) ϩ RNA was isolated from pools of oocytes/ embryos to screen a representative number of in-vitro and in-vivoderived embryos for the presence or absence of the specific gene transcripts at the various stages during preimplantation development. Each stage was assayed in at least three replicates using different batches of oocytes/embryos derived from different in-vitro production runs employing various pool sizes. Pool sizes ranged from four oocytes/embryos (one oocyte/embryo equivalent per specific gene) to 61 oocytes [40 oocyte equivalents for bLIF, 10 oocyte equivalents for gp130 and LR-β respectively, and one oocyte equivalent for Poly(A)] and 25 embryos [20 embryo equivalents for bLIF, two embryo equivalents for gp130 and LR-β respectively, and one embryo equivalent for Poly(A)] per RNA-isolation replicate resulting in the use of one oocyte/embryo equivalent to 40 oocyte and 10 embryo equivalents per specific transcript investigated in each RT-PCR run (for details see Figure 1) . One oocyte or embryo equivalent was always used for amplification of Poly(A)polymerase as positive control for the presence of RNA.
Detection of LIF-LIF-receptor system mRNA in single bovine embryos
After determining the mRNA expression pattern for the LIF-LIFreceptor system during embryonic development, single oocytes/ embryos were used for Poly(A) ϩ RNA-isolation and RT-PCR assay. As positive control for the presence of intact Poly(A) ϩ RNA a fragment of the Poly(A)polymerase was amplified from each sample RNA in a separate tube. After isolation of Poly(A) ϩ RNA from an individual oocyte/embryo the template RNA was diluted to 1/3 oocyte or embryo equivalent per 5.5 µl water. For each specific gene transcript [gp130, LR-β and Poly(A)] 1/3 oocyte or embryo equivalent was reverse transcribed and employed in PCR in a separate tube.
Results

Production and quality assessment of bovine embryos in vitro
A total of 5007 good quality COC were collected from 440 ovaries and used for the in-vitro production of bovine embryos in 21 replicates (Table II) . A total of 39 in-vitro derived representative day 8 blastocysts were successfully differentially stained and possessed a total of 170.1 Ϯ 6.7 cells of which 49.8 Ϯ 2.3 were allocated to the ICM corresponding to an ICM/total cells ratio of 29.7 Ϯ 1.1 %.
Detection of LIF-LIF-receptor system mRNA in bovine tissue and validation of the RT-PCR assay
The primer pair for bLIF spanned two introns resulting in a large, (in our hands not amplifiable), fragment from bovine genomic DNA. mRNA expression of bLIF was not detected in any of the tested tissues derived from a non-pregnant oestrous cow. However, in oviduct, placenta and corpus luteum from a cow in the first trimester of pregnancy a signal for bLIF was observed from 1 µg total RNA. From spleen and intestine tissue derived from the corresponding fetus strong signals for bLIF were found from 1 ng total RNA. RT-PCR with total RNA (1 µg) derived from maternal and fetal tissue from the third trimester of pregnancy did not show any signals for bLIF. The primers for gp130 did not work with genomic human or bovine DNA, indicating the presence of an intron. gp130 was present in the liver and corpus luteum of the oestrous cow, in the early pregnant uterus, placenta and corpus luteum (first trimester) as well as in spleen, intestine and liver tissue samples of the corresponding fetus, but not in maternal or fetal tissue from the third trimester of pregnancy. Total RNA (1-10 pg of fetal spleen) were giving a visible signal for gp130 after RT-PCR.
Signals for LR-β were found in the spleen from the first trimester fetus and within the liver of the corresponding mother using the primers (Tomida et al., 1993) with low amplification efficiency in bovine material. Employing the newly designed bovine-specific primer pair, LR-β mRNA was detected in fetal spleen and intestine (first and third trimester of pregnancy) as well as in the liver of the corresponding mothers using 1 pg of total RNA. The primers did not amplify bovine or human genomic DNA.
Signals for the fragments of bLIF-, gp130-and LR-β-transcripts as well as for Poly(A)polymerase were always detected in cumulus cells of all sources (fresh or cultured in vitro for different periods). Strong signals for each specific gene transcript were observed in all cumulus cell-RNA batches suggesting high amplification efficiency for each gene-specific RT-PCR assay.
Verification of the RT-PCR-products derived from bovine tissue and bovine embryos by sequencing revealed a high degree of homology with the previously published homologous or heterologous sequences: for bLIF there was a 99.9% identity with the bovine sequence (Brisson et al., 1996) , for gp130 a 93.2% identity with the human (Hibi et al., 1990) , a 85% identity with the murine (Saito et al., 1992) and a 85.3% identity with the rat (Wang et al., 1992) sequences, and for LR-β a 88% identity with the human sequence (Gearing et al., 1991) and a 80% with the murine sequence (Tomida et al., 1994) .
Detection of LIF-LIF-receptor system mRNA in pooled bovine embryos
gp130 transcripts were detected from all embryonic stages investigated irrespective of their origin using 1-10 oocyte or embryo equivalents for RT-PCR analysis (Figure 2) . LR-β transcripts were present in all developmental stages of in-vitro produced oocytes/embryos (1-10 embryo equivalents) but not detected in in-vivo produced embryos from the blastocyst stage onwards using similar embryo pool sizes (1-2 embryo equivalents) for RT-PCR as for the in-vitro derived counterparts at the corresponding developmental stage (Figure 2 ).
Whereas one oocyte/embryo equivalent was sufficient to detect gp130 and LR-β transcripts in all in-vitro produced embryonic stages, bLIF transcripts were only detected in larger pools of embryos, but never in immature oocytes and morulae and inconsistently in matured oocytes and blastocysts ( Figures  1 and 2) . No bLIF-transcripts were observed in in-vivo generated embryos with similar pool sizes (up to 20 blastocysts) as for in-vitro produced embryos at the corresponding developmental stage. While in pools of 10 8-16-cell embryos a fragment for bLIF was detected which corresponds to a total RNA-content of 8 ng, no bLIF-fragment could be amplified from RNA derived from 20 matured oocytes which corresponds to 48 ng total RNA, from two blastocysts (10 ng total RNA) or 20 morulae (14 ng total RNA) (Bilodeau-Goeseels and . The bLIF fragment was always detected from Ͻ14 ng cumulus cell mRNA. bLIF mRNA was more often detectable with increasing size of oocyte/embryo pools which could be attributed to a higher probability for the presence of several oocytes/embryos possessing bLIF mRNA.
Detection of LIF-LIF-receptor system mRNA in single bovine embryos
It was not possible to detect the fragment for bLIF in one embryo equivalent at any embryonic stage derived in vitro or in vivo (see above). From the immature oocyte up to the zygote the mRNA expression pattern for gp130, LR-β and Poly(A) was identical (Table III) . The gp130 transcript was not detected in three out of 10 embryos between the 2-16-cell stage. In in-vivo generated embryos, LR-β mRNA expression ceased during blastocoel expansion. The mRNA expression followed a similar stage specific pattern in all embryos as found in pooled material.
Discussion
This study is the first direct comparison of the expression pattern of the LIF-LIF-receptor system in in-vitro and in-vivo 12) and in-vivo (lanes 13-15)-derived oocytes/embryos employing reverse transcriptionpolymerase chain reaction (RT-PCR) using either one oocyte/ embryo equivalent (eq) for LR-β, gp130, Poly(A), or different pool sizes for bLIF, see below for details. MWT ϭ molecular weight marker. Lanes 1-3: negative controls omitting either sample RNA (lane 1) or reverse transcriptase (lane 2) or employing medium in the RT-PCR assay. Lane 4: positive control using mRNA isolated from cumulus cells derived from 15 cumulus oocyte complexes. Lane 5: immature oocytes (40 eq for bLIF). Lane 6: matured oocytes (40 eq for bLIF). Lane 7: zygotes (20 eq for bLIF). Lane 8: 2-4-cell stages (20 eq for bLIF). Lane 9: 8-16-cell stages (10 eq for bLIF). Lane 10: morulae (20 eq for bLIF). Lane 11: blastocysts (10 eq for bLIF). Lane 12: hatched blastocysts (2 eq for bLIF). Lane 13: in-vivo derived morulae (1 eq for bLIF). Lane 14: in-vivo derived blastocysts (20 eq for bLIF). Lane 15: in-vivo derived hatched blastocyst (2 eq for bLIF).
derived preimplantation embryos from a domestic species. A highly sensitive, simple, rapid and robust one step RT-PCR assay was developed to detect these rare gene transcripts from as little as 1/3 bovine oocyte. This assay is faster and less sensitive to contamination in comparison with nested or heminested approaches previously employed for the detection of 962 the LIF-LIF-receptor system in single human preimplantation embryos (Sharkey et al., 1995; VanEijk et al., 1996) . It allows the investigation of single cells for the presence or absence of at least three different gene transcripts at the same time. However, quantification of the mRNA expression pattern was not possible with this assay.
The apparent differences in bLIF expression pattern between in-vivo and in-vitro derived embryos and the inconsistent results within different embryo pools of the same size suggest a highly variable stage specific maternal and/or embryonic transcription pattern. This cannot be attributed to variations in RNA-concentrations used for RT-PCR since constant and stable RNA-recovery rates of 40-50% were reported with the same extraction method (Wrenzycki et al., 1998b) . This implies that bLIF has either no major physiological role or, more likely, a physiological function at very low expression levels, as suggested for transcripts involved in gene regulation or in signalling cascades (Smith and Rathjen, 1991; Rappolee et al., 1992) . Thus, bLIF-expression could be a sensitive and fast reacting check-point for major regulation of the LIF-LIFreceptor system. This is supported by the finding that LIFtranscription can be induced by many factors, even in the presence of inhibitors of de-novo protein synthesis, indicating a direct pathway of transcriptional regulation (Smith and Rathjen, 1991) . The occasional presence of bLIF mRNA expression in matured oocytes might be attributed to oestradiolmediated up-regulation of bLIF-production (Reinhart et al., 1998) as this hormone was present in our in-vitro maturation system. As Poly(A)polymerase transcripts are present throughout bovine preimplantation embryo development (Wrenzycki et al., 1998a) it cannot be ruled out that differences in polyadenylation status or conformational changes (for review see Spirin, 1994) affected bLIF-RNA-stability (Newman and Dai, 1996; Lequarre et al., 1997a,b; Brevini-Gandolfi et al., 1998) . However, potential effects of poly(A)tail length on RT-PCR results were unlikely as we primed with random hexamers during the RT.
The appearance of bLIF mRNA expression at the zygotic stage and not at the oocyte could be attributed to changes in polyadenylation of the bLIF mRNA before onset of the embryonic genome activation (Shim et al., 1997; Temeles and Schultz, 1997) . Our method is sensitive enough to detect the start of the minor activation of the bovine embryonic genome already at the zygotic stage. This early activation was previously shown in murine (Schultz et al., 1995) and bovine embryos (Barnes and First, 1991; Hay-Schmidt et al., 1997) and is in contrast to other methodological approaches (Viuff et al., 1996; Memili et al., 1998) in which the onset was determined at the 2-cell or 4-cell stage. Down-regulation of bLIF transcription at the morula stage might be a prerequisite for differentiation into ICM and trophectoderm and blastocoel formation.
The maternal as well as embryonic transcription pattern for the two receptor subunits LR-β and gp130 in in-vitro derived bovine embryos found in our study was similar to that seen in in-vitro cultured human embryos using hemi-nested RT-PCR (Sharkey et al., 1995; Van Eijk et al., 1996) . In contrast, in the mouse, both transcripts were exclusively detected in post-compaction stages (Nichols et al., 1996) using one PCR amplification round and in-vivo derived embryos. This indicates species differences and/or perturbations of expression patterns that can be attributed to in-vitro culture conditions or different methodological approaches. Investigating single bovine embryos from the immature oocyte up to the zygote the mRNA expression pattern for gp130, LR-β and Poly(A) indicated stable maternal transcripts. The lack of gp130 transcripts in some embryos between the 2-16-cell stage suggested a higher sensitivity to degradation or insufficient activation of the embryonic genome.
As mainly bLIF and LR-β were affected by culture conditions it could be assumed that in cattle the specific LIF-LIF-receptor system does not have the same essential physiological role during preimplantation development as in the mouse. Presumably, this system could be substituted by other cytokines, e.g. interleukin-6 (IL-6), oncostatin M (OSM), interleukin-11 (IL-11) or ciliary neurotrophic factor (CNTF) (Hilton, 1992) or cardiotrophin-1 (CT-1) (Pennica et al., 1995) sharing the gp130 subunit as receptor which was expressed constantly in embryos derived from both origins.
Our findings suggest a perturbed status of early differentiation in the in-vitro produced bovine blastocyst. During blastocoel formation the specific LIF-LIF-receptor system needs to be down-regulated to slow down proliferation to allow sufficient time for the organization of cellular arrangements and cell differentiation (VanSoom et al., 1997) . Proliferation of functional trophectodermal cells could be accelerated by LIFpersistence in vitro as previously shown for in-vitro cultured murine embryos (Lavranos et al., 1995) and by the relatively high total cell numbers in our in-vitro generated blastocysts. Variation in the ratio of ICM to trophectoderm cells within invitro generated embryos of this study or in-vivo generated embryos from other studies (Kreysing et al., 1997; VanSoom et al., 1997) cannot account for the obvious differences in mRNA expression. However, the differential staining technique provides only an insight into morphological criteria with regard to functionality of the tight junctions protecting the inner cells from antibody binding and complement-induced lysis and does not elucidate the functional differentiation status of the individual cell. Localization of LIF-and LR-β-transcripts within the embryo should clarify their function in bovine embryos and may provide more information on the developmental programme of the cells.
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Cumulus cells are a source for bLIF in culture indicating a paracrine effect on preimplantation embryo development as well as a possible autocrine effect on cumulus cell proliferation. These cells could consequently support in-vitro development of the embryos as known for other supportive LIF-producing cell-types (Smith et al., 1987; Desai and Goldfarb, 1996; Reinhart et al., 1998) . The beneficial effects of exogenously added LIF on bovine embryo development (Margawati et al., 1995a,b) , in particular in the absence of sufficient endogenous embryo-derived LIF (immature oocyte, between compaction and hatching), are likely to be mediated via both receptor subunits. However, further information on the protein level of the bovine LIF-LIF-receptor system including regulating mechanisms, binding proteins and/or alternative splicing variants of the receptor subunits (Layton et al., 1992; Narazaki et al., 1993; Reinhart et al., 1998) . To avoid serum-induced up-regulation of cytokine-expression (Smith and Rathjen, 1991) our medium contained BSA and cumulus cells and therefore could have been contaminated with binding-proteinlike substances. These could trap bLIF protein and cause an up-regulation of bLIF transcription. BSA has recently been suggested to mask effects of exogenously added hLIF in the early pig embryo (Eckert et al., 1997) .
If the bovine LIF-LIF-receptor system plays a similar essential role in implantation as in the mouse needs further investigation. It is conceivable that either the LIF-LIF-receptor system is switched on again upon implantation or that other cytokines, e.g. CNTF, IL-6, IL-11, OSM or CT-1 (Hilton, 1992; Pennica et al., 1995) take over its role in bovine implantation which is supported by the lack of LIF-effect to enhance pregnancy rates upon embryo transfer (Fry, 1992) . Obviously the persistent expression of the specific LIF-LIFreceptor system compared with their in-vivo counterparts does not block implantation of in-vitro-derived blastocysts as we observed 50% pregnancy rates after transfer of in-vitro produced embryos (Pavlok et al., 1992) .
In conclusion, we have developed a sensitive and rapid one step RT-PCR protocol for the analysis of single bovine oocytes/ embryos to study expression of the bovine LIF-LIF-receptor system. mRNA expression of the LIF-specific parts of the system is up-regulated by in-vitro culture which could lead to abnormal differentiation within the bovine in-vitro generated blastocyst. Future studies elucidating localization and functionality including the protein level should help to clarify the physiological role of the LIF-LIF-receptor system during bovine preimplantation embryo development. This could not only lead to optimization of culture conditions but also help in increasing the efficiency of generating appropriate cell lines in cattle which contribute to normal embryo development upon nuclear transfer procedures.
